Hudson Canyon Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.98M Sell
3,316
-264
-7% -$270K 2.13% 12
2026
Q1
$3.29M Sell
3,580
-20
-0.6% -$20.3K 2.02% 13
2025
Q4
$3.87M Sell
3,600
-123
-3% -$118K 2.26% 9
2025
Q3
$3.34M Sell
3,723
-123
-3% -$91.5K 1.92% 13
2025
Q2
$3M Sell
3,846
-79
-2% -$61.4K 1.87% 13
2025
Q1
$3.24M Sell
3,925
-758
-16% -$631K 2.28% 8
2024
Q4
$3.62M Hold
4,683
2.36% 9
2024
Q3
$4.15M Hold
4,683
2.68% 7
2024
Q2
$4.24M Sell
4,683
-671
-13% -$537K 2.87% 6
2024
Q1
$4.17M Hold
5,354
2.68% 8
2023
Q4
$3.12M Sell
5,354
-121
-2% -$70.6K 2.27% 9
2023
Q3
$2.94M Sell
5,475
-517
-9% -$266K 2.41% 7
2023
Q2
$2.81M Sell
5,992
-190
-3% -$79.7K 2.22% 7
2023
Q1
$2.12M Sell
6,182
-33
-0.5% -$11.1K 1.78% 14
2022
Q4
$2.27M Sell
6,215
-785
-11% -$278K 2.1% 9
2022
Q3
$2.26M Sell
7,000
-400
-5% -$127K 2.25% 7
2022
Q2
$2.4M Sell
7,400
-1,507
-17% -$452K 2.31% 6
2022
Q1
$2.55M Hold
8,907
2.02% 12
2021
Q4
$2.46M Sell
8,907
-442
-5% -$112K 1.79% 15
2021
Q3
$2.16M Sell
9,349
-351
-4% -$86.6K 1.66% 21
2021
Q2
$2.23M Sell
9,700
-743
-7% -$149K 1.67% 23
2021
Q1
$1.95M Sell
10,443
-974
-9% -$191K 1.53% 28
2020
Q4
$1.93M Buy
+11,417
New +$1.7M 1.53% 28

Other funds holding LLY

Hudson Canyon Capital Management's LLY Position: Q2 2026 in Review

Hudson Canyon Capital Management reduced its Eli Lilly (LLY) stake by 7.4% in Q2 2026, selling an estimated $270K and leaving 3,316 shares worth $3.98M. The position accounts for 2.13% of the portfolio, ranked #12.

Hudson Canyon Capital Management first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.24M in Q2 2024. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hudson Canyon Capital Management held 3,316 shares of Eli Lilly worth $3.98M as of Q2 2026.
  • Hudson Canyon Capital Management sold 264 Eli Lilly shares in Q2 2026, an estimated $270K.
  • Eli Lilly made up 2.13% of Hudson Canyon Capital Management's portfolio in Q2 2026, its #12 holding.
  • Hudson Canyon Capital Management first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • Hudson Canyon Capital Management's Eli Lilly position peaked at $4.24M in Q2 2024.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hudson Canyon Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.